Detalhe da pesquisa
1.
The COMPARE head-to-head, randomized controlled trial of SEL-212 (pegadricase plus rapamycin-containing nanoparticle, ImmTOR™) versus pegloticase for refractory gout.
Rheumatology (Oxford)
; 63(4): 1058-1067, 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37449908
2.
Anti-GM-CSF otilimab versus tofacitinib or placebo in patients with active rheumatoid arthritis and an inadequate response to conventional or biologic DMARDs: two phase 3 randomised trials (contRAst 1 and contRAst 2).
Ann Rheum Dis
; 82(12): 1516-1526, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37699654
3.
Anti-GM-CSF otilimab versus sarilumab or placebo in patients with rheumatoid arthritis and inadequate response to targeted therapies: a phase III randomised trial (contRAst 3).
Ann Rheum Dis
; 82(12): 1527-1537, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37696589
4.
Long-term safety and efficacy of sarilumab with or without background csDMARDs in rheumatoid arthritis.
Rheumatology (Oxford)
; 62(10): 3268-3279, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36727470
5.
Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease.
Rheumatology (Oxford)
; 62(5): 1877-1886, 2023 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36173318
6.
International Dermatology Outcome Measures (IDEOM) - Report from the 2022 Annual Meeting.
J Drugs Dermatol
; 22(12): 1153-1159, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38051841
7.
A pilot study to evaluate the safety and efficacy of treprostinil in the treatment of calcinosis in systemic sclerosis.
Rheumatology (Oxford)
; 61(6): 2441-2449, 2022 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34718447
8.
Inhibition of structural joint damage progression with upadacitinib in rheumatoid arthritis: 1-year outcomes from the SELECT phase 3 program.
Rheumatology (Oxford)
; 61(8): 3246-3256, 2022 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34897366
9.
Expert Opinion on Pegloticase with Concomitant Immunomodulatory Therapy in the Treatment of Uncontrolled Gout to Improve Efficacy, Safety, and Durability of Response.
Curr Rheumatol Rep
; 24(1): 12-19, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35167037
10.
International Dermatology Outcome Measures (IDEOM): Report from the 2020 Annual Meeting.
Dermatology
; 238(3): 430-437, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34537770
11.
The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases.
J Allergy Clin Immunol
; 147(3): 814-826, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33129886
12.
Upadacitinib improves patient-reported outcomes vs placebo or adalimumab in patients with rheumatoid arthritis: results from SELECT-COMPARE.
Rheumatology (Oxford)
; 60(12): 5583-5594, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33590829
13.
Upadacitinib monotherapy improves patient-reported outcomes in rheumatoid arthritis: results from SELECT-EARLY and SELECT-MONOTHERAPY.
Rheumatology (Oxford)
; 60(7): 3209-3221, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33313898
14.
Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis.
Rheumatology (Oxford)
; 60(3): 1137-1147, 2021 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32864685
15.
Dual trajectories of fatigue and disease activity in an inception cohort of adults with systemic lupus erythematosus over 10 years.
Lupus
; 30(4): 578-586, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33413006
16.
Patient-reported outcome measures in systemic lupus erythematosus by a web-based application: A randomized, crossover, agreement study.
Lupus
; 30(13): 2124-2134, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34719299
17.
Pain and Fatigue in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors: Multinational Real-World Findings.
J Clin Rheumatol
; 27(8): e446-e455, 2021 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32826654
18.
Upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naïve Japanese patients with rheumatoid arthritis: a sub-analysis of the Phase 3 SELECT-EARLY study.
Mod Rheumatol
; 31(3): 534-542, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33164611
19.
Report of the Skin Research Working Groups From the GRAPPA 2020 Annual Meeting.
J Rheumatol Suppl
; 97: 10-16, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34074659
20.
Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working Group.
J Rheumatol Suppl
; 97: 60-63, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34074670